Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
45°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anixa Biosciences Inc
(NQ:
ANIX
)
2.730
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.730
Bid (Size)
2.690 (3)
Ask (Size)
2.850 (1)
Prev. Close
2.730
Today's Range
2.730 - 2.730
52wk Range
2.700 - 5.130
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via
Investor Brand Network
Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 07, 2024
Via
ACCESSWIRE
Performance
YTD
-30.53%
-30.53%
1 Month
-9.30%
-9.30%
3 Month
-29.27%
-29.27%
6 Month
-5.86%
-5.86%
1 Year
-19.94%
-19.94%
More News
Read More
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
March 20, 2024
Via
AB Newswire
Recap: Anixa Biosciences Q1 Earnings
March 12, 2024
Via
Benzinga
Sidoti Events, LLC's Virtual January Micro-Cap Conference
January 15, 2024
Via
ACCESSWIRE
6 Analysts Have This to Say About Anixa Biosciences
June 19, 2023
Via
Benzinga
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
December 20, 2023
Via
Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
December 11, 2023
Via
InvestorPlace
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
September 11, 2023
Via
InvestorPlace
The Latest Analyst Ratings for Anixa Biosciences
May 23, 2023
Via
Benzinga
Expert Ratings for Anixa Biosciences
April 18, 2023
Via
Benzinga
Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 10, 2023
Via
ACCESSWIRE
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 09, 2023
Via
Benzinga
Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
July 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
Via
Benzinga
Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
December 27, 2022
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 16, 2022
Via
Benzinga
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
September 19, 2022
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
August 15, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
